Status:
COMPLETED
Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Fibromyalgia
FMS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effect a morning light treatment has on improving physical function, pain intensity, and pain sensitivity in people with fibromyalgia syndrome (FMS).
Eligibility Criteria
Inclusion
- • Meet criteria for Fibromyalgia syndrome (FMS)
Exclusion
- Significant chronic disease
- Severe hearing or memory problems
- Pending medical leave applications at workplace
- Current pregnancy, breastfeeding, or actively trying to get pregnant
- Night work or travel outside the eastern time zone within 1 month of the study
- Other research participation
- Frequent number of special events during study period (weddings, concerts, exams, etc).
Key Trial Info
Start Date :
January 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03794908
Start Date
January 31 2019
End Date
July 15 2021
Last Update
October 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Michigan
Ann Arbor, Michigan, United States, 48109